Montelukast Sodium
Product Images NDC 42254-263

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 42254-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 01)

FDA Label Image

Chemical Structure (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 02)

FDA Label Image

Figure 2 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 03)

This appears to be a graph or chart indicating the Mean Percent Change from Baseline over 15 weeks in a treatment that includes 9 weeks of "Montelukast Sodium" and 6 weeks of "Washout". The chart also includes a comparison to a placebo treatment.*

FDA Label Image

Montelukast Sodium (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.